Valuation Metrics and Recent Changes
As of 17 Feb 2026, Kingfa Science’s P/E ratio stands at 33.43, a figure that, while still elevated, marks a moderation from previous levels that contributed to its earlier expensive rating. The price-to-book value ratio is currently 7.71, indicating a premium valuation but one that aligns more closely with industry norms than before. These valuation metrics have been pivotal in the company’s downgrade from a Buy to a Hold rating on 15 Feb 2026, as reflected in its Mojo Score of 65.0 and Mojo Grade of Hold.
Other valuation multiples such as EV to EBIT (26.29) and EV to EBITDA (23.40) remain on the higher side, signalling that the market continues to price in strong operational performance and growth expectations. The PEG ratio, a measure of valuation relative to earnings growth, is notably high at 8.59, suggesting that the stock’s price growth may be outpacing its earnings growth potential.
Comparative Analysis with Industry Peers
When benchmarked against its peers in the Plastic Products - Industrial sector, Kingfa Science’s valuation appears more balanced. For instance, Finolex Industries, rated as Fair, trades at a P/E of 23.32 and EV/EBITDA of 18.85, while Time Technoplast, considered Attractive, has a P/E of 21.81 and EV/EBITDA of 11.83. On the other end of the spectrum, companies like Shaily Engineering and Safari Industries remain Very Expensive, with P/E ratios exceeding 50 and EV/EBITDA multiples above 30.
This relative positioning underscores Kingfa Science’s transition towards a fair valuation, especially when considering its robust return on capital employed (ROCE) of 27.19% and return on equity (ROE) of 23.06%, which are among the stronger performers in the sector. These quality metrics support the company’s premium valuation but also highlight the need for valuation moderation to reflect sustainable growth prospects.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Price Performance and Market Context
Kingfa Science’s stock price has experienced a recent decline, with a day change of -4.08%, closing at ₹4,145.00 compared to the previous close of ₹4,321.50. The stock’s 52-week high is ₹4,987.00, while the low stands at ₹2,451.00, indicating significant volatility over the past year. Despite short-term weakness, the company has delivered exceptional long-term returns, with a 10-year stock return of 816.04% compared to the Sensex’s 259.08% over the same period.
However, in the near term, Kingfa Science has underperformed the broader market. Its one-week return of -7.03% and one-month return of -4.06% lag behind the Sensex’s respective gains of -0.94% and -0.35%. Year-to-date, the stock is down 6.75%, while the Sensex has declined by 2.28%. This relative underperformance has contributed to the reassessment of the stock’s valuation and rating.
Quality and Financial Strength
Kingfa Science’s strong ROCE of 27.19% and ROE of 23.06% reflect efficient capital utilisation and profitability, which are critical factors supporting its valuation. The company’s EV to capital employed ratio of 7.54 and EV to sales of 2.99 further indicate a premium pricing relative to its operational scale. These metrics suggest that while the stock is no longer deemed expensive, it remains fairly valued given its quality and growth prospects.
Investors should note that the absence of a dividend yield (NA) may influence total returns, especially for income-focused portfolios. The elevated PEG ratio of 8.59 also warrants caution, as it implies that earnings growth expectations are priced aggressively, which could lead to valuation pressure if growth slows.
Is Kingfa Science & Technology (India) Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Implications for Investors
The downgrade from Buy to Hold reflects a more cautious stance amid valuation normalisation and recent price weakness. While Kingfa Science’s fundamentals remain robust, the stock’s premium multiples and high PEG ratio suggest limited upside in the near term without a corresponding acceleration in earnings growth.
Investors should weigh the company’s strong historical returns and quality metrics against the current valuation environment. The stock’s fair valuation grade indicates that it is no longer richly priced but still commands a premium relative to many peers. This balance suggests that Kingfa Science may be suitable for investors with a medium to long-term horizon who can tolerate short-term volatility.
Comparatively, peers such as Time Technoplast and EPL Ltd offer more attractive valuations with lower P/E and EV/EBITDA multiples, potentially providing better entry points for value-oriented investors. Conversely, companies like Shaily Engineering and Safari Industries remain expensive, underscoring Kingfa Science’s relative appeal within the sector.
Historical Context and Future Outlook
Over the past decade, Kingfa Science has delivered extraordinary returns, outperforming the Sensex by a wide margin. This track record highlights the company’s ability to generate shareholder value through innovation and operational excellence in the plastic products industry.
Looking ahead, sustaining such growth will be critical to justify current valuations. Market participants will closely monitor earnings momentum, margin trends, and capital allocation efficiency. Any signs of deceleration could prompt further valuation adjustments, while positive surprises may restore a more bullish outlook.
Given the current market dynamics and valuation shifts, a Hold rating appears prudent, signalling that investors should maintain positions but remain vigilant for changes in fundamentals or market sentiment.
Conclusion
Kingfa Science & Technology’s transition from an expensive to a fair valuation grade marks a significant development in its market narrative. The moderation in P/E and P/BV ratios, coupled with strong profitability metrics, positions the stock as fairly valued within its sector. However, elevated multiples and recent price declines warrant a cautious approach.
Investors are advised to consider the company’s long-term growth potential alongside its current valuation and peer comparisons. While the stock remains a quality name in the plastic products industry, alternative opportunities with more attractive valuations exist, underscoring the importance of portfolio diversification and active monitoring.
Unlock special upgrade rates for a limited period. Start Saving Now →
